UK Life Sciences and Healthcare Newsletter
February 19, 2021
We are pleased to present the February issue of Dechert LLP’s UK Life Sciences and Healthcare Newsletter.
This month's Newsletter provides an insight into current developments, analysis and news, including:
- An update in relation to a recent draft EU Regulation that aims to encourage the sharing and re-use of data
- An update on the latest development in the warranty and indemnity (W&I) insurance market: synthetic warranty coverage, and its possible application in the transaction process.
- A Committed Capital podcast episode discussing various opportunities affecting private equity investment in life sciences and healthcare and how the U.S. and European markets are shaping up in 2021 and beyond
- A guest contributor feature from David Miles, CEO of AKL Research and Development: "Are We Nearly There Yet? The Search for a Disease Modifying Drug for Osteoarthritis"